Abstract

To measure the mass transfer and clearance of procalcitonin (PCT) in patients with septic shock during continuous venovenous hemofiltration (CVVH), and to assess the mechanisms of elimination of PCT. The medical department of intensive care. A prospective, observational study. Thirteen critically ill patients with septic shock and oliguric acute renal failure requiring continuous venovenous postdilution hemofiltration with a high-flux membrane (AN69 or polyamide) and a 'conventional' substitution volume (< 2.5 l/hour). PCT was measured with the Lumitest PCT Brahms(R) in the prefilter and postfilter plasma, in the ultrafiltrate at the beginning of CVVH (T0) and 15 min (T15'), 60 min (T60') and 6 hours (T6h) after setup of CVVH, and in the prefilter every 24 hours during 4 days. Mass transfer was determined and the clearance and the sieving coefficient were calculated according to the mass conservation principle. Plasma and ultrafiltrate clearances, respectively, at T15', T60' and T6h were 37 +/- 8.6 ml/min (not significant) and 1.8 +/- 1.7 ml/min (P < 0.01), 34.7 +/- 4.1 ml/min (not significant) and 2.3 +/- 1.8 ml/min (P < 0.01), and 31.5 +/- 7 ml/min (not significant) and 5 +/- 2.3 ml/min (P < 0.01). The sieving coefficient significantly increased from 0.07 at T15' to 0.19 at T6h, with no difference according to the nature of the membrane. PCT plasma levels were not significantly modified during the course of CCVH. We conclude that PCT is removed from the plasma of patients with septic shock during CCVH. Most of the mass is eliminated by convective flow, but adsorption also contributes to elimination during the first hours of CVVH. The effect of PCT removal with a conventional CVVH substitution fluid rate (<2.5 l/hour) on PCT plasma concentration seems to be limited, and PCT remains a useful diagnostic marker in these septic patients. The impact of high-volume hemofiltration on the PCT clearance, the mass transfer and the plasma concentration should be evaluated in further studies.

Highlights

  • Procalcitonin (PCT) is induced in the plasma of patients with sepsis and septic shock, and is a very useful marker to monitor treatment in critically ill patients [1]

  • We conclude that PCT is removed from the plasma of patients with septic shock during CCVH

  • Most of the mass is eliminated by convective flow, but adsorption contributes to elimination during the first hours of continuous venovenous hemofiltration (CVVH)

Read more

Summary

Introduction

Procalcitonin (PCT) is induced in the plasma of patients with sepsis and septic shock, and is a very useful marker to monitor treatment in critically ill patients [1] This polypeptide of 166 amino acids is increased in generalized bacterial or fungal infections, whereas neither local bacterial or viral infection colonization only leads to a small elevation or no elevation of PCT. An early decline of PCT is observed in patients who recovered and survived, and PCT can be used as an adequate treatment indicator This marker of inflammation homeostasis seems more specific and sensitive to monitor septic patients as compared with C-reactive protein, or even cytokines that are not so easy to routinely measure

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call